ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3661 - 3675 of 5996 products
China to Announce New National Drug Reimbursement List
$0.00
Available
Vincent Medical Strikes $3 Million Medical Device Deal with Israel's Inovyte
$5.00
Available
FibroGen's Novel Anemia Treatment Meets Phase III Endpoints in China
$5.00
Available
Yaohua Medical Instrument Inks Agreement for Cervical Cancer Scan in China
$5.00
Available
BeiGene Starts Global Phase III Trial of BTK Inhibitor
$5.00
Available
Nhwa Pharma Acquires China Rights to Emergency Treatment for Blood Loss
$5.00
Available
Temasek Invests $800 Million in Google's Verily Life Sciences
$5.00
Available
Neovia, a Seattle-Beijing JV, Starts US Trial of Cancer Drug
$5.00
Available
New China Policy Puts Pressure on Drug Distributors to Consolidate
$5.00
Available
WuXi Biologics Files for $300 Million (?) Hong Kong IPO
$5.00
Available
Suzhou Connect Biopharma Closes Early Fundings for $25 Million
$5.00
Available
Beijing Mabworks Completes $39 Million B Funding
$5.00
Available
Aslan Pharma Approved to List Shares on Taiwan's Main Board
$5.00
Available
Sanpower and CITIC to Raise $2.9 Billion for Sanpower's Healthcare M&A
$5.00
Available
Wondfo Biotech Participates in Atlas Genetics' $35 Million Round
$5.00
Available